baber/WOPTO huggingface dataset:
Patent NZ-583061-A (NZ)
Title: 4-(9-(3,3-difluorocyclopentyl)-5,7,7-trimethyl-6-oxo-6,7,8,9-tetrahydro-5h-pyrimido[4,5-b[1,4]diazepin-2-ylamino)-3-methoxybenzamide derivatives as inhibitors of the human protein kinases plk1 to plk4 for the treatment of proliferative diseases
Inventor: PIERARD FRANCOISE
IPC: A61K31/551
Filed: 2008-08-15
Abstract: Disclosed is a compound of formula (I) where the substituents are as disclosed in the description. Examples of compounds of formula (I) are N-cyclopropyl-4-(9-(3,3-difluorocyclopentyl)-5,7,7-trimethyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-ylamino)-3-methoxybenzamide; 4-(9-(3,3-difluorocyclopentyl)-5,7,7-trimethyl-6-oxo-6,7,8,9-tetrahydro-5Hpyrimido[4,5-b][1,4]diazepin-2-ylamino)-N-(3-fluorocyclopentyl)-3-methoxybenzamide and N-(3,3-difluorocyclopentyl)-4-(9-(3,3-difluorocyclopentyl)-5,7,7-trimethyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido[4,5-b][1,4]diazepin-2-ylamino)-3-methoxybenzamide. Also disclosed is a pharmaceutical composition comprising a compound of formula (I), the use of a compound of formula (I) in the manufacture of a medicament for inhibiting protein kinase activity, a method for inhibiting protein kinase activity in a biological sample and a process for preparing a compound of formula (I).
Patent NZ-584242-A (NZ)
Title: Device for filling the container of collapsible type comprising a first and second transport units
Inventor: GUSTAFSSON PER
IPC: B65B43/12
Filed: 2008-09-26
Abstract: Disclosed is a method and device for filling collapsible containers made from polymer film that are stored on a roll as a continuous web to allow high capacity filling. The method for filling containers of a collapsible type, comprises the steps of providing a web roll that includes the containers in an interconnected state, feeding the web for transporting the containers in a first longitudinal direction, whereby the containers are oriented in the first longitudinal direction. An end seal is removed during the transport in the first longitudinal direction, provided on each container for opening a filling duct. The containers are separated during the transport in the first longitudinal direction while maintaining their orientation in the first longitudinal direction, and in a second transverse direction transverse to the first longitudinal direction while filling with a liquid product.
Patent NZ-586551-A (NZ)
Title: Single component intake/exhaust valve member, fuel distribution system, and cooling system for combustion-powered fastener-driving tool
Inventor: ADAMS JOSEPH S
IPC: B25C1/08
Filed: 2008-12-30
Abstract: A combustion chamber system 100 comprises a combustion chamber 102 defined around an axis and into which an air-fuel mixture is to be charged, ignition means disposed within the combustion chamber 102 for igniting the air-fuel mixture disposed within the combustion chamber 102, and a single component intake/exhaust valve 112 movably disposed within the combustion chamber 102 between first CLOSED and second OPEN positions for controlling the intake of air into the combustion chamber 102 and the exhaust of combustion products out from the combustion chamber 102. A first combustion air intake port 126 is defined within an upper side wall portion of the combustion chamber 102 and a second combustion product exhaust port 130 is defined within an upper wall portion of the combustion chamber 102. The single component intake/exhaust valve 112 has an annular configuration which permits combustion air to enter the first combustion air intake port 126 for flow into the combustion chamber 102 and combustion products to be exhausted from the combustion chamber 102 through the second combustion product exhaust port 130, when the single component intake/exhaust valve 112 is disposed at the second OPEN position. When the valve 112 is at the first open position, it prevents combustion air from entering the first combustion air intake port 126 for flow into the combustion chamber 102, and it also prevents combustion products from being exhausted from the combustion chamber 102 through the second combustion product exhaust port 130. The annularly configured single component intake/exhaust valve 112 and the upper wall portion of the combustion chamber 102 defining the second combustion product exhaust port 130 comprise oppositely oriented flanged portions such that when the single component intake/exhaust valve 112 is disposed at the first OPEN position, the combustion air entering the first combustion air intake port 126 for flow into the combustion chamber 102 will traverse a sinusoidal flow path.
Patent NZ-587620-A (NZ)
Title: Making a winding for a slotless stator by collapsing coil groups into a single layer web with interleaving coil segments
Inventor: SUZUKI HIROSHI
IPC: H02K15/04
Filed: 2007-12-26
Abstract: A poly-phase field winding (70) for a slotless stator is disclosed. The poly phase field winding (72) comprises a plurality of coil windings (ABC) arranged in a first coil group (72) and second coil group (74). There is a single layer cylindrical web including the first coil group (72) and the second coil group (74) that is collapsed such that coil winding segments (A1, B1 and C1) formed on a first side of a mandrel (16) are interleaved with the coil winding segments (A2, B2 and C2) formed on the opposite side of the mandrel(16). The coil winding segments (A1, B1, C1; A2, B2, C2) are arranged in parallel and do not overlap. Each of the coil winding segments (A1, B1 and C1) from the first coil group (72) is positioned opposite a corresponding coil winding segments (A2, B2 and C2) from the second group (74).
Patent NZ-588374-A (NZ)
Title: Tetrazole compounds for reducing uric acid
Inventor: O'NEIL JAMES DENNEN
IPC: A01N43/64
Filed: 2009-04-30
Abstract: Disclosed is a compound of formula (XLVI). Examples of compounds of formula (I) are: 5-(3-(2,6-Dimethylbenzyloxy)-4-methoxybenzyl)-1H-tetrazole; 5-(3-(2,6-Dimethylbenzyloxy)phenethyl)-1H-tetrazole; and 5-(3-(2,6-Dimethylbenzyloxy)-4-methylbenzyl)-1H-tetrazole. The compounds are useful for reducing uric acid levels. The uric acid-lowering effects of the compounds disclosed are used to treat or prevent a variety of conditions including gout, hyperuricemia, elevated levels of uric acid that do not meet the levels customarily justifying a diagnosis of hyperuricemia, renal dysfunction, kidney stones, cardiovascular disease, risk for developing cardiovascular disease, tumour-lysis syndrome, cognitive impairment, early-onset essential hypertension, and Plasmodium falciparum-induced inflammation. Also disclosed are pharmaceutical compositions comprising a compound of formula (XLVI).
Patent NZ-588855-A (NZ)
Title: Device for the manufacture of multiple grooved wire using multiple sets of rollers space circumferentially around the rod
Inventor: MCDONALD DANIEL P
IPC: B21H1/20
Filed: 2009-03-10
Abstract: 588855 Disclosed is a method for forming a asymmetric multiple grooved wire, the method comprising pulling a wire through a first set of rollers, the first set of rollers having groove-forming protrusions forming grooves in the wire, the first set of rollers defining gaps between the grooves; and pulling the wire through a second set of rollers, the second set of rollers having groove forming protrusions and forms grooves in the wire in the gaps formed by the first set of rollers.
Patent NZ-588868-A (NZ)
Title: Processing biomass
Inventor: MEDOFF MARSHALL
IPC: C12N1/20
Filed: 2009-04-28
Abstract: Disclosed is a method comprising: converting a low molecular weight sugar, said sugar being a carbohydrate or a derivative thereof in a mixture with a fibrous biomass, a microorganism, and water, to a product other than sugar, wherein the biomass comprises a cellulosic or lignocellulosic material and has been irradiated prior to mixing with the low molecular weight sugar, and wherein the converting comprises fermentation.
Patent NZ-593502-A (NZ)
Title: A multivitamin/mineral formulation to combat the effects of environmental stress; improve immunity and improve energy while addressing vitamin and mineral deficiencies without the negative side effects of a mega dose nutritional supplement
Inventor: MOHS CHARLES
IPC: A23L33/155
Filed: 2010-01-21
Abstract: Abstract 593502 The disclosure relates to a composition comprising vitamin B1, vitamin B2, niacin, vitamin B6, pantothenic acid, vitamin E, vitamin C and selenium, wherein the weight ratio of biotin to vitamin B1 is between 1:20 to 1:25; wherein the weight ratio of biotin to vitamin B2 is between 1 :20 to 1 :25; wherein the weight ratio of biotin to niacin is between 1:310 to 1:330; wherein the weight ratio of biotin to vitamin B6 is between 1:30 to 1:35; wherein the weight ratio of biotin to pantothenic acid is between 1:110 to 1:130; wherein the weight ratio of selenium to vitamin E is between 1:450 to 1:550, and wherein the weight ratio of selenium to vitamin C is between 1:3000 to 1:3500. The composition is intended to provide a nutritional supplement to assure adequate intake of micronutrients without the negative side effects of a megadose nutritional supplement.
Patent NZ-594155-A (NZ)
Title: Methods for amplifying hepatitis c virus nucleic acids
Inventor: KWONG ANN D
IPC: C12Q1/68
Filed: 2010-01-21
Abstract: 594155 Disclosed is a method of amplifying a hepatitis C virus (HCV) nucleic acid from an HCV infected sample, comprising amplifying a segment of a DNA template complementary to a genome of HCV RNA from the sample by a two-stage polymerase chain reaction (PCR), wherein a first stage PCR employs a first outer primer and a second outer primer, and a second stage PCR employs a first inner primer and a second inner primer, wherein i) the nucleotide sequence of the first outer primer comprises SEQ ID NO: 2: 5'-GAGTAGTGTTGGGTCG-3' (SEQ ID NO: 2), ii) the nucleotide sequence of the second outer primer comprises SEQ ID NO: 3 or SEQ ID NO: 4: 5'-CACGCTGTGATAAATG-3' (SEQ ID NO: 3) or 5'-CAVGCTGTGATATATG-3' (SEQ ID NO: 4), wherein V is A, C or G; iii) the nucleotide sequence of the first inner primer comprises SEQ ID NO: 5: 5'-GGTGCTTGCGAGTGCC-3' (SEQ ID NO: 5), and iv) the nucleotide sequence of the second inner primer comprises SEQ ID NO: 6 or SEQ ID NO: 7: 5'-TAGCCAGCCGTGAACC-3' (SEQ ID NO: 6) or 5'-TARCCAGCRACGAACC-3' (SEQ ID NO: 7), wherein R is A or G, wherein each of the inner and outer primers independently is a 15-50 mer, and wherein the amplified HCV nucleic acid has greater than 8,000 base pairs.
Patent NZ-595413-A (NZ)
Title: Benzodiazepine derivative for the treatment of hematopoietic neoplasm and leukemia
Inventor: CHEDID MARCIO
IPC: A61K31/5517
Filed: 2010-04-08
Abstract: 595413 Disclosed herein is the use of 7-(2,5-dihydro-4-imidazo[1,2-a]pyridine-3-yl-2,5-dioxo-1H-pyrrol-3-yl)-9-fluoro-1,2,3,4-tetrahydro-2-(1-piperidinylcarbonyl)pyrrolo[3,2,1-jk][1,4] benzodiazepine or a pharmaceutically acceptable salt or a solvate thereof for the preparation of a medicament for the treatment of a leukemia selected from the group consisting of: mixed lineage leukemia; translocated mixed lineage leukemia; translocated mixed lineage leukemia based acute myelogenous leukemia; translocated mixed lineage leukemia based acute lymphoid leukemia; a non-MLL based chronic myeloproliferative disorder; and a non-MLL based acute lymphoid leukemia.
Patent NZ-597840-A (NZ)
Title: Apparatus for producing x-rays for use in imaging
Inventor: YODER RODNEY B
IPC: G01N23/20
Filed: 2010-08-06
Abstract: 597840 An apparatus (10) for producing x-rays for use in imaging applications is disclosed. The apparatus comprises a piezoelectric or pyroelectric crystal (14) with a conducting film (18) coating the upper surface of the crystal. The crystal includes a plurality of electron field emitters (16) formed as micrometer-scale regions in the crystal (14) with one or more peaks or ridges. The apparatus further includes a means for controlling temperature for a pyroelectric crystal or means for controlling strain for a piezoelectric crystal and the crystal is maintained in a low pressure environment.
Patent NZ-598826-A (NZ)
Title: Belt drive conveyor with power tap off
Inventor: BRAYMAN MATTHEW T
IPC: B65G23/14
Filed: 2010-09-28
Abstract: 598826 A modular conveyor system 20 comprises a transport member having a conveying surface 26 that is configured to transport articles in a transport direction, an endless strip extending along the transport member, a drive for propelling the endless strip and a power tap off between the strip and the transport member. The transport member is divided into a plurality of tandem units each having a conveying surface 26. The power tap off has an input that is driven by the strip and an output that drives the transport member. The power tap off provides a positive transfer of power from the strip to the transport member. At least one of the tandem units comprises a diverter. The transport member comprises a transport surface of the diverter. The transport surface of the diverter comprises a plurality of belts that are interspersed between transfer members of a right angle transfer. The plurality of belts are movably supported by a pair of rollers. The power tap off drives one of the pair of rollers. The diverter can be positioned at substantially any location along the transport member. At least one of the pair of rollers has a crowned surface at each of the plurality of belts to track the corresponding one of the plurality of belts. Each crowned surface comprises an elastic band stretched over the at least one rollers.
Patent NZ-598854-A (NZ)
Title: Flushable moist wipe or hygiene tissue
Inventor: STRANDQVIST MIKAEL
IPC: A47K7/00
Filed: 2009-10-16
Abstract: 598854 Disclosed is a flushable moist wipe or hygiene tissue which comprises a hydraulically entangled nonwoven material impregnated with a wetting composition. The nonwoven material contains at least 70%, by fibre weight, pulp fibres and the rest manmade fibres and/or natural fibres with a length of at least 6 millimetres and up to 15 millimetres. The moist wipe or hygiene tissue has a length in the machine direction which exceeds the width in the cross-machine direction by at least 25%. The moist wipe or hygiene tissue has a wet strength in machine direction which is at least 3 times higher than the wet strength in cross-machine direction, wherein the wet strength in crossmachine direction is between 50 and 200 N/m. The moist wipe has a basis weight of between 40 and 100 g/m². The moist wipe further contains a wet strength agent of not more than 0.1% by weight, as calculated on the dry weight. The moist tissue will retain its structural integrity in its wiping function and is able to disintegrate in a sewer when flushed.
Patent NZ-599321-A (NZ)
Title: High-purity large-scale preparation of stannsoporfin
Inventor: DRUMMOND GEORGE S
IPC: A61K31/555
Filed: 2007-10-04
Abstract: ABSTRACT - 599321 The disclosure relates to a composition comprising stannsoporfin, wherein said stannsoporfin is at least about 98.5% pure and where any individual impurity present is present in an amount of less than about 0.1 %, wherein the composition has a pH of 7.0 to 8.0, and wherein the composition may further comprise a buffer selected from a phosphate, citrate, gluconate, lactate, tartrate, glycinate, glycylglycinate, bicarbonate, carbonate, maleate, acetate, histidine, imidazole and combinations thereof.
Patent NZ-601240-A (NZ)
Title: Vertical quilt basting frame
Inventor: CROSSE ANN
IPC: D05B91/10
Filed: 2010-12-15
Abstract: Disclosed is a vertical quilt basting frame (100). The disclosure notes that the present vertical quilt basting frames allows easy access to both sides of a quilt. The vertical quilt basting frame (100) comprises four frame members (105, 110, 115, 120), at least one leg member (125), a plurality of fabric side panels (150, 155, 160, 165) and a plurality of fabric reducing panels . The four frame members (105, 110, 115, 120) define a rectangle. The at least one leg member (125) extends from at least one of the frame members (105, 110, 115, 120). The plurality of fabric side panels (150, 155, 160, 165) are attached to each of the four frame members (105, 110, 115, 120) wherein the fabric side panels (150, 155, 160, 165) define a first workspace window (170) inside the rectangle. The plurality of fabric reducing panels are attached to the plurality of fabric side panels (150, 155, 160, 165) and define a reduced size first workspace window (170).
Patent NZ-602549-A (NZ)
Title: Centrifugal pump
Inventor: DAUGAARD POUL ANTON
IPC: F04D7/04
Filed: 2011-05-03
Abstract: 602549 A centrifugal pump that comprises a casing in which an impeller (1) is arranged. The impeller has a back side (2) that faces a back plate of the centrifugal pump, and one or more vanes (51-55) for pumping the fluid. The back side of the impeller comprises a segmented scraper (3) for scraping from the back plate material that has been deposited from the fluid. The segmented scraper comprises multiple protrusions (101-118), wherein each protrusion of the multiple protrusions is facing the back plate, at least two (104, 105) of the multiple protrusions are arranged at various radial distances from a centre of the impeller, and an aggregated radial extension of the protrusions equals a radius of the impeller within an interval of ± 10%, ± 25% or even up to ± 40%.
Patent NZ-602703-A (NZ)
Title: Arylfluorophosphate inhibitors of intestinal apical membrane sodium/phosphate co-transport
Inventor: SLOMOWITZ LARRY
IPC: A61K31/683
Filed: 2011-03-04
Abstract: The present disclosure is directed to fluorophosphates of formula (I), and pharmaceutical compositions thereof, which are inhibitors of intestinal apical sodium/phosphate co-transport and are useful in the treatment of hyperphosphatemia, in reducing blood phosphate levels, and in treating hypertension. Example of a compound of formula (I) is 2’-fluorophosphophloretin (2’-FPP).
Patent NZ-602943-A (NZ)
Title: Modified binding proteins inhibiting the vegf-a receptor interaction
Inventor: BINZ HANS KASPAR
IPC: C07K14/47
Filed: 2011-04-29
Abstract: Disclosed is a recombinant binding protein comprising an ankyrin repeat domain comprising the amino acid sequence 1 to 126 of SEQ ID NO: 3 and a polyethylene glycol of at least 5 kDa molecular weight, wherein SEQ ID NO: 3 is disclosed in the specification. Also disclosed is the use of such binding proteins in the manufacture of a medicament for treating pathological angiogenesis.
Patent NZ-605888-A (NZ)
Title: Pharmaceutical dosage form comprising 6’-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4’,9’-dihydro-3’h-spiro[cyclohexane-1,1’-pyrano[3,4,b]indol]-4-amine for the treatment of nociceptive pain
Inventor: FRIEDRICH INGO
IPC: A61K9/48
Filed: 2011-08-04
Abstract: Disclosed is the use of a pharmaceutical dosage form containing a pharmacologically active agent formulated for oral administration once daily in the manufacture of a medicament for the treatment of nociceptive pain, wherein the pharmacologically active agent is selected from 6’-fluoro-N,N-dimethyl-4-phenyl-4’,9’-dihydro-3’H-spiro[cyclohexane-1,1’-pyrano[3,4-b]indol]-4-amine or 6’-fluoro-N-methyl-4-phenyl-4’,9’-dihydro-3’H-spiro[cyclohexane-1,1’-pyrano[3,4-b]indol]-4-amine (including cebranopadol) or a physiologically acceptable salt thereof; and which contains the pharmacologically active agent in a dose of from 150 µg to 800 µg, expressed as weight equivalent dosages based upon the free base.
Patent NZ-607121-A (NZ)
Title: Personal aircraft
Inventor: KROO ILAN
IPC: B64D41/00
Filed: 2011-07-19
Abstract: A personal aircraft includes a fuselage 107, a forward wing 104 coupled to the fuselage and located forward of a centre of gravity, and an aft wing 105 coupled to the fuselage and located aft of the centre of gravity. Mounting booms 114 extend along port and starboard sides of the fuselage supported by a plurality of struts 116, and a plurality of lift rotors 101, each rotor mounted on the respective mounting boom between the forward wing and the aft wing on either side of the fuselage, at least two and preferably at least three per side, each produces an amount of vertical thrust independent of levels of vertical thrust produced by the other rotors. Propellers 103 coupled to the fuselage, or mounted on the high aft wing, provide forward thrust. The rotors and propellers may be powered by light-weight electric motors powered from a battery that may be charged by an internal combustion engine powered generator. The front and rear wings may be vertically offset.
Patent NZ-607792-A (NZ)
Title: Improved vaccine compositions
Inventor: SCHRÖDER ULF
IPC: A61K39/39
Filed: 2011-09-30
Abstract: Disclosed is the use of: i) one or more antigens and ii) an adjuvant, said adjuvant comprising one or more carboxylic acids and optionally one or more mono-glycerides in the manufacture of a vaccine composition for avoiding Bell’s palsy in a frequency higher than the naturally occurring incidence, following vaccination in a human.
Patent NZ-610073-A (NZ)
Title: Housing for receiving a trailer module
Inventor: ALEXANDER WYSTRON
IPC: H01R13/627
Filed: 2013-05-01
Abstract: 610073 A housing (1) for receiving a trailer module which provides the circuitry which is required for electrically contacting a trailer with a towing vehicle. The housing (1) aims to provide a permanently reliable tightness against water while simultaneously requiring a simple assembly. The housing (1) has a housing chamber (2) which provides a volume space (3) for receiving the trailer module, a housing cover (5) which comprises a grommet (6), with the housing cover (5) and the grommet (6) in one piece made of an elastic plastic material, and a retaining ring (8) which carries locking hooks (9) on the side of the housing chamber (2). The housing chamber (2) has a circumferential stop collar (11) on the side of the housing cover (5), which stop collar (11) comprises recesses (12) corresponding to the locking hooks (9) of the retaining ring (8). The housing cover (5) has a circumferential attached flange (13) corresponding to the stop collar (11) of the housing chamber (2) on the side of the housing chamber (2).
Patent NZ-618435-A (NZ)
Title: A timber-working device and method of operation
Inventor: DOUGLAS CRAIG SWINYARD
IPC: B27B31/06
Filed: 2013-12-02
Abstract: A forestry tree felling head (4) is disclosed. The head is configured for processing multiple stems (50, 51) at a time, in which stems may be fed through the head independently from each other, to automatically align them before bucking. The head has a frame with a feed axis and a drive system (11a-b, 12a-b) configured to position a first stem on a first side of the feed axis and a second stem on a second side of the feed axis. A first end sensor (17a) having a first sensing region (52a) extending into the first side of the feed axis is configured to output a signal indicative of the presence of an end of the first stem within the first sensing region. A second end sensor (17b) having a second sensing region (52b) extending into the second side of the feed axis is configured to output a signal indicative of the presence of an end of the second stem within the second sensing region. A controller is fed these signals and independently operated feed rollers of the drive system adjust the stems such that their ends substantially align to be cut by the cutter (15).